首页> 美国卫生研究院文献>Blood >Neoplasia: Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma
【2h】

Neoplasia: Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma

机译:瘤形成:CCND1 mRNA的截断改变了套细胞淋巴瘤中miR-16-1的调节

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cyclin D1 (CCND1) is a well-known regulator of cell-cycle progression. It is overexpressed in several types of cancer including breast, lung, squamous, neuroblastoma, and lymphomas. The most well-known mechanism of overexpression is the t(11;14)(q13;q32) translocation found in mantle cell lymphoma (MCL). It has previously been shown that truncated CCND1 mRNA in MCL correlates with poor prognosis. We hypothesized that truncations of the CCND1 mRNA alter its ability to be down-regulated by microRNAs in MCL. MicroRNAs are a new class of abundant small RNAs that play important regulatory roles at the posttranscriptional level by binding to the 3′ untranslated region (UTR) of mRNAs blocking either their translation or initiating their degradation. In this study, we have identified the truncation in CCND1 mRNA in MCL cell lines. We also found that truncated CCND1 mRNA leads to increased CCND1 protein expression and increased S-phase cell fraction. Furthermore, we demonstrated that this truncation alters miR-16-1 binding sites, and through the use of reporter constructs, we were able to show that miR-16-1 regulates CCND1 mRNA expression. This study introduces the role of miR-16-1 in the regulation of CCND1 in MCL.
机译:细胞周期蛋白D1(CCND1)是细胞周期进程的著名调节剂。它在几种类型的癌症中过表达,包括乳腺癌,肺癌,鳞状细胞瘤,神经母细胞瘤和淋巴瘤。最著名的过表达机制是套细胞淋巴瘤(MCL)中发现的t(11; 14)(q13; q32)易位。先前已显示,MCL中CCND1 mRNA的缩短与预后不良相关。我们假设CCND1 mRNA的截断改变了其被MCL中的microRNA下调的能力。 MicroRNA是一类新型的丰富小RNA,它们通过与mRNA的3'非翻译区(UTR)结合而阻止转录或启动其降解,从而在转录后水平上发挥重要的调控作用。在这项研究中,我们已经鉴定出MCL细胞系中CCND1 mRNA的截短。我们还发现,截短的CCND1 mRNA导致CCND1蛋白表达增加和S期细胞分数增加。此外,我们证明了这种截短改变了miR-16-1的结合位点,并且通过使用报告基因构建体,我们能够证明miR-16-1调节CCND1 mRNA的表达。本研究介绍了miR-16-1在MCL中调控CCND1的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号